Teva Pharmaceutical Industries valuation
$42.62Change from previous close: +0.12%Absolute change: +$0.05
Valuation
The P/E ratio is 99.0. The average price target of 14 analysts is $50.29.
Data as of November 17, 2026
Teva Pharmaceutical Industries compared with similar companies
Teva Pharmaceutical Industries's P/E (trailing 12 months): 99.0, +176% against the median of a group of 9 similar companies (35.9).
| Metric | Teva Pharmaceutical Industries | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 99.0 | 35.9 | 22.2 – 64.5 | High |
| Forward P/E | 13.6 | 19.5 | 14.1 – 31.2 | Low |
| EV/EBITDA | 14.2 | 17.0 | 14.2 – 26.0 | Middle |
| Price/book | 6.23 | 4.99 | 4.42 – 6.39 | Middle |
| Price/sales | 2.88 | 4.05 | 2.95 – 7.34 | Low |
| Gross margin | 53.5% | 67.5% | 64.7% – 77.4% | Low |
| Operating margin | 19.8% | 23.4% | 19.3% – 27.2% | Middle |
| Net margin | 2.9% | 16.2% | 7.8% – 24.5% | Low |
| ROE | 6.7% | 12.0% | 8.0% – 17.8% | Low |
| Debt/equity | 2.13 | 0.50 | 0.12 – 2.13 | Middle |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Other metrics
Valuation multiples
- Market cap
- $49.67B
- Enterprise value
- $62.59B
- PEG
- 0.71
- EV/revenue
- 3.63
Profitability and growth
- ROA
- 5.4%
- Revenue growth (year over year)
- -1.9%
- Earnings growth (year over year)
- -46.0%
Financial health
- Total cash
- $4.08B
- Total debt
- $17B
- Current ratio
- 0.95
- Quick ratio
- 0.51
Dividends
- Payout ratio
- 0.0%
- Ex-dividend date
- November 28, 2017
Analysts and estimates
- Average price target
- $50.29
- Median price target
- $49.50
- High price target
- $57.00
- Low price target
- $42.12
- Analysts with a price target
- 14
- Consensus
- Buy
- Forward EPS
- $3.12
- EPS estimate, current year
- $2.07
Shares and trading
- Beta
- 0.84
- Average volume
- 6.09M
- Shares outstanding
- 1.17B
- Float
- 1.09B
- Institutional ownership
- 58.9%
- Insider ownership
- 0.6%
- Short interest (% of float)
- 2.4%
- Short ratio (days)
- 4.49
